Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Cell Mol Life Sci ; 77(17): 3423-3439, 2020 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-31722069

RESUMO

SUGCT (C7orf10) is a mitochondrial enzyme that synthesizes glutaryl-CoA from glutarate in tryptophan and lysine catabolism, but it has not been studied in vivo. Although mutations in Sugct lead to Glutaric Aciduria Type 3 disease in humans, patients remain largely asymptomatic despite high levels of glutarate in the urine. To study the disease mechanism, we generated SugctKO mice and uncovered imbalanced lipid and acylcarnitine metabolism in kidney in addition to changes in the gut microbiome. After SugctKO mice were treated with antibiotics, metabolites were comparable to WT, indicating that the microbiome affects metabolism in SugctKO mice. SUGCT loss of function contributes to gut microbiota dysbiosis, leading to age-dependent pathological changes in kidney, liver, and adipose tissue. This is associated with an obesity-related phenotype that is accompanied by lipid accumulation in kidney and liver, as well as "crown-like" structures in adipocytes. Furthermore, we show that the SugctKO kidney pathology is accelerated and exacerbated by a high-lysine diet. Our study highlights the importance of non-essential genes with no readily detectable early phenotype, but with substantial contributions to the development of age-related pathologies, which result from an interplay between genetic background, microbiome, and diet in the health of mammals.


Assuntos
Envelhecimento , Coenzima A-Transferases/genética , Microbioma Gastrointestinal , Síndrome Metabólica/patologia , Animais , Antibacterianos/farmacologia , Bactérias/genética , Bactérias/isolamento & purificação , Carnitina/análogos & derivados , Carnitina/metabolismo , Coenzima A-Transferases/deficiência , Suplementos Nutricionais , Fezes/microbiologia , Microbioma Gastrointestinal/efeitos dos fármacos , Humanos , Rim/metabolismo , Rim/patologia , Metabolismo dos Lipídeos , Fígado/metabolismo , Fígado/patologia , Lisina/administração & dosagem , Síndrome Metabólica/metabolismo , Metaboloma/efeitos dos fármacos , Camundongos , Camundongos Knockout , Obesidade/metabolismo , Obesidade/patologia , Triptofano/metabolismo
2.
FASEB J ; 24(3): 844-52, 2010 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-19890015

RESUMO

Cerebral selenium (Se) deficiency is associated with neurological phenotypes including seizures and ataxia. We wanted to define whether neurons require selenoprotein expression and which selenoproteins are most important, and explore the possible pathomechanism. Therefore, we abrogated the expression of all selenoproteins in neurons by genetic inactivation of the tRNA[Ser](Sec) gene. Cerebral expression of selenoproteins was significantly diminished in the mutants, and histological analysis revealed progressive neurodegeneration. Developing interneurons failed to specifically express parvalbumin (PV) in the mutants. Electrophysiological recordings, before overt cell death, showed normal excitatory transmission, but revealed spontaneous epileptiform activity consistent with seizures in the mutants. In developing cortical neuron cultures, the number of PV(+) neurons was reduced on combined Se and vitamin E deprivation, while other markers, such as calretinin (CR) and GAD67, remained unaffected. Because of the synergism between Se and vitamin E, we analyzed mice lacking neuronal expression of the Se-dependent enzyme glutathione peroxidase 4 (GPx4). Although the number of CR(+) interneurons remained normal in Gpx4-mutant mice, the number of PV(+) interneurons was reduced. Since these mice similarly exhibit seizures and ataxia, we conclude that GPx4 is a selenoenzyme modulating interneuron function and PV expression. Cerebral SE deficiency may thus act via reduced GPx4 expression.-Wirth, E. K., Conrad, M., Winterer, J., Wozny, C., Carlson, B. A., Roth, S., Schmitz, D., Bornkamm, G. W., Coppola, V., Tessarollo, L., Schomburg, L., Köhrle, J., Hatfield, D. L., Schweizer, U. Neuronal selenoprotein expression is required for interneuron development and prevents seizures and neurodegeneration.


Assuntos
Interneurônios/fisiologia , Degeneração Neural/metabolismo , Degeneração Neural/prevenção & controle , Convulsões/metabolismo , Convulsões/prevenção & controle , Selenoproteínas/fisiologia , Animais , Western Blotting , Calbindina 2 , Diferenciação Celular/efeitos dos fármacos , Células Cultivadas , Eletrofisiologia , Glutationa Peroxidase/metabolismo , Glutationa Peroxidase/fisiologia , Imuno-Histoquímica , Interneurônios/efeitos dos fármacos , Interneurônios/metabolismo , Camundongos , Camundongos Knockout , Parvalbuminas/metabolismo , Parvalbuminas/fisiologia , Fosfolipídeo Hidroperóxido Glutationa Peroxidase , Aminoacil-RNA de Transferência/genética , Aminoacil-RNA de Transferência/fisiologia , Proteína G de Ligação ao Cálcio S100/metabolismo , Proteína G de Ligação ao Cálcio S100/fisiologia , Selênio/farmacologia , Selenoproteínas/metabolismo , Vitamina E/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA